Investing Profile

Ari Nowacek

InvestorVC
Principal at ARCH Venture Partners
Photo of Ari Nowacek, Principal at ARCH Venture Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$50K - $150.0M
$25.0M
4
$635.8M
CompanyStageDateRound SizeTotal Raised
City Therapeutics
Series AOct 2024$140M
$140M
Co-investors: Robert Nelsen (ARCH Venture Partners)
Synchron
Series CDec 2022$75M
$120M
Co-investors: Robert Nelsen (ARCH Venture Partners), Christian Angermayer (Presight Capital), Thomas Reardon (PSG)
HiberCell
Series BMay 2021$67M
Series AFeb 2019$61M
$130M
Co-investors: Steven Gillis (ARCH Venture Partners)